Is VYNE or XBIT more undervalued in 2026?

CirclFi compares VYNE Therapeutics Inc. (VYNE) and XBiotech Inc. (XBIT) using 13 institutional-grade valuation models. VYNE has a Quality of Company score of 4.6/10 while XBIT scores 4.7/10.

Which is a better buy — VYNE or XBIT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do VYNE and XBIT valuations compare?

VYNE at $0.68 and XBIT at $2.42 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

VYNE vs XBIT Valuation Comparison 2026 — Intrinsic Value Analysis

VYNE

Pharmaceutical Preparations

VYNE Therapeutics Inc.

Quality

4.6

out of 10

Value Trap

LOW

Price

$0.68

Last close

Models

9/13

Active

XBIT

Pharmaceutical Preparations

XBiotech Inc.

Quality

4.7

out of 10

Value Trap

SAFE

Price

$2.42

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	VYNE Fair Value	VYNE Upside	XBIT Fair Value	XBIT Upside
Bayesian DCF	Intrinsic	$0.58	-14.7%	$2.56	+5.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.33	+242.3%	$4.70	+94.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for VYNE vs XBIT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VYNE vs XBIT — Which Stock Is More Undervalued?

XBIT scores higher with a 4.7/10 quality rating vs VYNE's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing VYNE Therapeutics Inc. (VYNE) and XBiotech Inc. (XBIT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VYNE currently trades at $0.68 with a QOC of 4.6/10, while XBIT trades at $2.42 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).